A qualitative study of perceptions of meaningful change in spinal muscular atrophy
Autor: | Kenneth Hobby, Jill Jarecki, Sarah McGraw, Jeff Henne, Wei-Shi Yeh, Ying Qian |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Adult Male Parents medicine.medical_specialty Activities of daily living Adolescent Health Personnel Clinical Neurology 030105 genetics & heredity lcsh:RC346-429 Muscular Atrophy Spinal 03 medical and health sciences Young Adult 0302 clinical medicine Physical medicine and rehabilitation Quality of life Activities of Daily Living medicine Humans Respiratory function Functional ability Patient Reported Outcome Measures Child lcsh:Neurology. Diseases of the nervous system Qualitative Research Patient perspectives business.industry Meaningful change Infant General Medicine Spinal muscular atrophy medicine.disease SMA Focus group Child Preschool Physical therapy Quality of Life Female Neurology (clinical) business Qualitative 030217 neurology & neurosurgery Qualitative research Research Article |
Zdroj: | BMC Neurology BMC Neurology, Vol 17, Iss 1, Pp 1-9 (2017) |
ISSN: | 1471-2377 |
Popis: | Background This qualitative study examined how individuals with Spinal Muscular Atrophy (SMA), their caregivers, and clinicians defined meaningful change, primarily in the Type II and non-ambulant type III patient populations, associated with treatment of this condition. In addition, we explored participants’ views about two measures of motor function routinely used in clinical trials for these SMA subtypes, namely the expanded version of the Hammersmith Functional Motor Scale (HFMSE) and the Upper Limb Module (ULM). Methods The 123 participants (21 with SMA, 64 parents, and 11 clinicians), recruited through SMA advocacy organizations, participated in one of 16 focus groups or 37 interviews. The sessions were audio-recorded, and verbatim transcripts were analyzed using a grounded theory approach. Results For the participants, meaningful change was relative to functional ability, and small changes in motor function could have an important impact on quality of life. Because patients and families feared progressive loss of functional ability, the participants saw maintenance of abilities as a meaningful outcome. They believed that measures of motor function covered important items, but worried that the HFMSE and ULM might not be sensitive enough to capture small changes. In addition, they felt that outcome measures should assess other important features of life with SMA, including the ability to perform daily activities, respiratory function, swallowing, fatigue, and endurance. Conclusions Given the heterogeneity of SMA, it is important to expand the assessment of treatment effects to a broader range of outcomes using measures sensitive enough to detect small changes. |
Databáze: | OpenAIRE |
Externí odkaz: |